Related Experiment Video
Updated: Aug 9, 2026
09:27
Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
Published on: January 5, 2016
Serum alpha2-macroglobulin levels in tuberose sclerosis
Journal of Mental Deficiency Research
|December 1, 1976
Summary
Serum alpha2-macroglobulin (alpha2-MG) levels are significantly elevated in individuals with tuberous sclerosis compared to controls. This finding may aid in understanding the condition and its genetic counseling.
Area of Science:
- Biochemistry
- Genetics
- Dermatology
Background:
- Tuberous sclerosis is a genetic disorder affecting multiple organs.
- Alpha2-macroglobulin (alpha2-MG) is a key proteinase inhibitor in serum.
- Previous research on alpha2-MG levels in tuberous sclerosis is limited.
Purpose of the Study:
- To investigate serum alpha2-macroglobulin (alpha2-MG) levels in patients with tuberous sclerosis.
- To compare alpha2-MG levels between tuberous sclerosis patients and healthy controls.
- To explore the potential implications of altered alpha2-MG levels in tuberous sclerosis.
Main Methods:
- Serum samples were collected from 54 tuberous sclerosis patients and 47 age- and sex-matched controls.
- Alpha2-macroglobulin (alpha2-MG) levels were quantified using radial immunodiffusion.
- Statistical analysis was performed to compare groups.
Main Results:
- Tuberous sclerosis patients exhibited significantly higher serum alpha2-MG levels compared to controls (p < 0.001).
- Elevated alpha2-MG levels were observed in both males and females with tuberous sclerosis.
- No significant sex-based difference in alpha2-MG levels was noted within the groups.
Conclusions:
- Serum alpha2-macroglobulin (alpha2-MG) is a potential biomarker for tuberous sclerosis.
- The findings suggest a possible role for alpha2-MG in the pathophysiology of tuberous sclerosis.
- Elevated alpha2-MG levels may be valuable for genetic counseling in tuberous sclerosis cases.
